Information
Editors
PiaHalonen
EijaHiltunen-Back
Pelvic Inflammatory Disease (Pid)
Essentials
- Pelvic inflammatory disease (PID) is an acute infection usually originating in the uterine cervix, which may cause endometritis, salpingitis, oophoritis, pelvic abscess, peritonitis and/or perihepatitis.
- Early diagnosis and treatment prevent late sequelae of PID:
- infertility due to fallopian tube damage
- ectopic pregnancy
- chronic abdominal pain.
Epidemiology
- PID mainly occurs in sexually active women of reproductive age. The risk of PID is highest in the youngest age groups.
- If the clinical picture in a postmenopausal patient resembles PID, careful differential diagnosis is required (high risk of malignancy).
- In 2019, the global age-standardized prevalence rate (ASPR) of PID was 53.19 per 100 000. For details, see http://pmc.ncbi.nlm.nih.gov/articles/PMC10544469/.
Aetiology
- Usually a mixed infection, and the causative pathogens cannot necessarily be detected by microbiological methods.
- Chlamydia trachomatisChlamydia and Neisseria gonorrhoeae Gonorrhoea often cause PID in women of reproductive age. An estimated 10-15% of cervical chlamydial or gonococcal infections proceed to PID.
- Mycoplasma genitalium is another probable cause of PID in premenopausal patients.
- Anaerobic bacteria in the vaginal microbiome may also be associated with PID.
- Intestinal or respiratory tract bacteria are involved more rarely.
- Inserting an IUD will increase the risk of PID for a few weeks.
Clinical picture
- The possibility of PID must be kept in mind if a patient of reproductive age presents with lower abdominal pain and abnormal vaginal discharge. The clinical diagnosis can be made based on typical symptoms and findings and basic investigations.
- The clinical picture varies from nearly asymptomatic to life-threatening.
- Symptoms
- Bilateral lower abdominal pain
- Pain on intercourse, pain on urination
- Abnormal vaginal discharge
- Intermenstrual bleeding, postcoital bleeding, purulent discharge
- Low-grade fever / fever
- Findings
- Palpation of the abdomen: tenderness of the lower abdomen
- Pelvic examination: cervical, uterine and adnexal tenderness
- Speculum examination: purulent or bloody cervical discharge
Workup
Basic investigations in outpatient care
- Basic blood count with platelet count, CRP (severe PID: leucocytosis and elevated CRP)
- Nucleic acid detection test for Chlamydia trachomatis and Neisseria gonorrhoeae (cervical or vaginal sample)
- Differential diagnosis
- Chemical screening of urine, bacterial culture of urine
- Total plasma hcG
- Nucleic acid detection test for Mycoplasma genitalium, as necessary (cervical or vaginal sample)
Further investigations in specialized care
- Transvaginal ultrasonography
- PID findings are often limited and open to interpretation.
- Findings clearly suggestive of PID: pyosalpinx, abscess
- Vaginal smear
- Absence of leucocytosis has good negative predictive value.
- Rarely endometrial biopsy
- MRI or CT mainly for differential diagnosis
- Laparoscopy mostly in PID refractory to conservative treatment
Treatment
- To avoid consequences affecting fertility, PID should be diagnosed and treatment started without hesitation in patients of reproductive age.
- Treatment should be chosen to cover the most important potential causative bacteria and also a mixed infection; treatment should be directed at chlamydia, gonorrhoea and anaerobic bacteria.
- Outpatient management if:
- the patient's general condition is good
- inflammatory markers are only slightly increased.
- Antimicrobial treatment in outpatient care
- Doxycycline 100 mg twice daily for 14 days and metronidazole 400 mg three times daily for 14 days
- If gonorrhoea is diagnosed
- a single dose of ceftriaxone 1 g i.m. should be added to the regimen, and
- a gonococcal culture sample should preferably be taken for antimicrobial susceptibility testing before starting the treatment (see Gonorrhoea).
- If gonorrhoea or chlamydia is diagnosed, ensure contact tracing (see Chlamydia).
- If chlamydial and gonococcal infections can be excluded and the infection occurs after the insertion of an IUD, for example, it is usually a mixed infection caused by normal vaginal flora.
- This can be treated with a combination of cephalexin (500 mg three times daily or 750 mg twice daily) and metronidazole (500 mg twice daily or 400 mg three times daily).
- Indications for hospital treatment
- Severe symptoms: high fever, poor general condition
- Complicated PID: suspected abscess in the lesser pelvis
- PID refractory to outpatient care
- Uncertain diagnosis, differential diagnostic problems
- Pregnant women
- Antimicrobial treatment in hospital
- Ceftriaxone 2 g i.v. once daily, doxycycline 100 mg i.v. or p.o. twice daily, metronidazole 400 mg i.v. or p.o. three times daily
- After the patient's clinical condition improves, intravenous antimicrobial treatment should be continued for another day. It can then be replaced by oral medication.
- Doxycycline 100 mg twice daily and metronidazole 400 mg three times daily to make the total duration of treatment 14 days
- Symptomatic treatment: NSAID, rest, sick leave
- If a patient with PID has an IUD, it should be removed if PID is refractory to antimicrobial treatment.
- Remember to arrange postcoital contraception and further contraception, as necessary.
- If PID was due to chlamydia or gonorrhoea, a control sample (nucleic acid detection test for chlamydia and gonorrhoea) should be taken 4 weeks after the end of treatment.
- The sexual partner(s) should be examined: samples for chlamydia and gonorrhoea tests.
Prognosis
- PID should be readily treated to prevent any late complications.
- PID may damage the fallopian tubes, leading to subfertility.
- A single case of PID with treatment begun at an early stage will hardly affect fertility.
- The risk of infertility is increased if the patient has had severe PID or several episodes of PID.
- PID may increase the risk of ectopic pregnancy to some extent.
- About 30% of patients develop chronic pelvic pain.
References
- Ross J, Guaschino S, Cusini M, et al. 2017 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS 2018;29(2):108-114 [PubMed]